Restructa pro injectione S (Acidum silicicum D8, Berberis vulgaris D4, Bryonia D4) solution for injection ampoules 2 ml. №5

$49.00

Manufacturer: Germany

As part of the complex tre payment of uric acid diathesis, gout, uroli this is, purine metaboliam disorders, arthritis.

Description

Restructa pro injectione S (Acidum silicicum D8, Berberis vulgaris D4, Bryonia D4) solution for injection ampoules 2 ml. №5

Composition

active substances: 2.0 ml of solution contains: Acidum silicicum D8 – 83 mg, Berberis vulgaris D4 – 143 mg, Bryonia D4 – 143 mg, Calcium hypophosphorosum D3 – 83 mg, Cinchona pubescens D4 – 83 mg, Coffeinum monohydricum D4 – 83 mg , Colchicum autumnale D4 – 143 mg, Convallaria majalis D4 – 83 mg, Echinacea D4 – 83 mg, Ferrum phosphoricum D10 – 83 mg, Formica rufa D10 – 83 mg, Formica rufa D4 – 83 mg, Formica rufa D6 – 83 mg, Lithium chloratum D3 – 83 mg, Rhus toxicodendron D4 – 146 mg, Salix alba D4 – 143 mg, Smilax D4 – 143 mg, Solidago virgaurea D3 – 83 mg;

excipients: sodium chloride, water for injections.

Medicinal form

Solution for injection.

Main physicochemical properties: transparent, colorless, odorless solution.

Pharmacotherapeutic group

Complex homeopathic medicine.

Pharmacological properties

A drug Restructa pro injectione S of metabolic, anti-inflammatory, analgesic, antirheumatic, diuretic, antiseptic action. The action of the medicinal product is based on the activation of the body’s protective forces and the normalization of impaired functions due to substances of plant, mineral and animal origin that are included in its composition.

Indication 

As part of a comprehensive treatment of uric acid diathesis, gout, urolithiasis, purine metabolism disorders, arthritis.

Contraindication

Hypersensitivity to any component of the drug.
Rheumatism, neoplasms.

Use during pregnancy or breastfeeding

Do not use during pregnancy or breastfeeding.

Method of application and dosage

Single dose: adults and children over 12 years – 1 ampoule of 2 ml. Use as intramuscular, subcutaneous, intradermal injections, children aged 12 years – 1-3 times a week.

The course of treatment is 4-6 weeks.

Children

The drug Restructa pro injectione S is recommended for the treatment of children over 12 years of age.

Overdose

Possible increase in adverse reactions; when using high doses of the drug may cause nausea, vomiting, diarrhea, insomnia, agitation.

Side effects

In isolated cases, there may be temporary allergic reactions, changes in the injection site, nausea, vomiting, diarrhea, abdominal pain. Echinacea-containing preparations have been associated with skin rash, pruritus, urticaria, agitation, and sleep disturbances.